首页> 外文期刊>Acta Pharmaceutica Sinica B >MicroRNAs in idiopathic pulmonary fibrosis: involvement in pathogenesis and potential use in diagnosis and therapeutics
【24h】

MicroRNAs in idiopathic pulmonary fibrosis: involvement in pathogenesis and potential use in diagnosis and therapeutics

机译:MicroRNA在特发性肺纤维化中的作用:参与发病机制以及在诊断和治疗中的潜在用途

获取原文
           

摘要

MicroRNAs (miRNAs) are a class of phylogenetically conserved, non-coding short RNAs, 19-22 nt in length which suppress protein expression through base-pairing with the 3'-untranslated region of target mRNAs. miRNAs have been found to participate in cell proliferation, differentiation and apoptosis. Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, and high lethality fibrotic lung disease for which currently there is no effective treatment. Some miRNAs have been reported to be involved in the pathogenesis of pulmonary fibrosis. In this review, we discuss the role of miRNAs in the pathogenesis, diagnosis and treatment of IPF.
机译:MicroRNA(miRNA)是一类系统发育上保守的非编码短RNA,长度为19-22 nt,可通过与靶mRNA的3'-非翻译区碱基配对来抑制蛋白质表达。已经发现miRNA参与细胞增殖,分化和凋亡。特发性肺纤维化(IPF)是一种慢性,进行性和高致死性的纤维化肺病,目前尚无有效的治疗方法。据报道,一些miRNA与肺纤维化的发病机理有关。在这篇综述中,我们讨论了miRNA在IPF的发病机理,诊断和治疗中的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号